CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Aspira Women''s Health Inc. - AWH CFD

3.9424
2.07%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading сonditions
Spread 0.0652
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 3.8624
Open* 3.6924
1-Year Change* 882.81%
Day's Range* 3.6924 - 3.9624
52 wk Range N/A
Average Volume (10 days) N/A
Average Volume (3 months) N/A
Market Cap N/A
P/E Ratio N/A
Shares Outstanding N/A
Revenue N/A
EPS N/A
Dividend (Yield %) N/A
Beta N/A
Next Earnings Date N/A

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Feb 29, 2024 3.9424 0.2500 6.77% 3.6924 3.9624 3.6924
Feb 28, 2024 3.8624 -0.0900 -2.28% 3.9524 3.9624 3.7424
Feb 27, 2024 4.0124 -0.0900 -2.19% 4.1024 4.2324 3.8924
Feb 26, 2024 4.1124 -0.2300 -5.30% 4.3424 4.3524 3.9924
Feb 23, 2024 4.3924 0.1100 2.57% 4.2824 4.4324 4.2424
Feb 22, 2024 4.2924 -0.3300 -7.14% 4.6224 4.6424 4.2624
Feb 21, 2024 4.6324 -0.2100 -4.34% 4.8424 4.8424 4.4924
Feb 20, 2024 4.8424 0.0100 0.21% 4.8324 4.8424 4.6624
Feb 16, 2024 4.7424 0.0400 0.85% 4.7024 4.9724 4.5224
Feb 15, 2024 4.7224 -0.0200 -0.42% 4.7424 4.8924 4.5124
Feb 14, 2024 4.7724 0.4200 9.65% 4.3524 4.9324 4.2924
Feb 13, 2024 4.6224 0.1300 2.89% 4.4924 4.7924 4.4424
Feb 12, 2024 4.7424 -0.0100 -0.21% 4.7524 4.8024 4.4424
Feb 9, 2024 4.7924 0.1900 4.13% 4.6024 4.9424 4.3324
Feb 8, 2024 4.6324 0.3400 7.92% 4.2924 4.6724 4.2924
Feb 7, 2024 4.2024 -0.3900 -8.49% 4.5924 4.6624 4.1824
Feb 6, 2024 4.5424 -0.0500 -1.09% 4.5924 4.8424 4.3124
Feb 5, 2024 4.7924 -0.0300 -0.62% 4.8224 5.0024 4.6324
Feb 2, 2024 5.2224 0.1300 2.55% 5.0924 5.3024 4.9624
Feb 1, 2024 5.2124 -0.1100 -2.07% 5.3224 5.3924 5.0024

Aspira Women''s Health Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 8.184 6.812 4.651 4.538 3.053
Revenue 8.184 6.812 4.651 4.538 3.053
Cost of Revenue, Total 3.865 3.75 3.415 3.343 3.142
Gross Profit 4.319 3.062 1.236 1.195 -0.089
Total Operating Expense 40.949 39.407 22.632 19.816 14.386
Selling/General/Admin. Expenses, Total 31.079 30.343 17.113 15.455 10.694
Research & Development 5.953 5.314 2.104 1.018 0.55
Operating Income -32.765 -32.595 -17.981 -15.278 -11.333
Interest Income (Expense), Net Non-Operating 0.017 -0.048 0.01 0.059 -0.022
Other, Net 5.578 0.981 0.066 -0.018 -0.016
Net Income Before Taxes -27.17 -31.662 -17.905 -15.237 -11.371
Net Income After Taxes -27.17 -31.662 -17.905 -15.237 -11.371
Net Income Before Extra. Items -27.17 -31.662 -17.905 -15.237 -11.371
Total Extraordinary Items
Net Income -27.17 -31.662 -17.905 -15.237 -11.371
Total Adjustments to Net Income 0
Income Available to Common Excl. Extra. Items -27.17 -31.662 -17.905 -15.237 -11.371
Income Available to Common Incl. Extra. Items -27.17 -31.662 -17.905 -15.237 -11.371
Diluted Net Income -27.17 -31.662 -17.905 -15.237 -11.371
Diluted Weighted Average Shares 7.76911 7.41441 6.71522 5.77333 4.67262
Diluted EPS Excluding Extraordinary Items -3.49718 -4.27033 -2.66633 -2.63921 -2.43354
Diluted Normalized EPS -3.32522 -4.27033 -2.66633 -2.63921 -2.43354
Unusual Expense (Income) 0.052
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 2.491 2.316 2.153 2.072 2.066
Revenue 2.491 2.316 2.153 2.072 2.066
Cost of Revenue, Total 0.941 1.125 0.917 0.916 1.1
Gross Profit 1.55 1.191 1.236 1.156 0.966
Total Operating Expense 6.812 8.085 7.754 11.769 10.286
Selling/General/Admin. Expenses, Total 5.178 5.729 5.747 8.696 7.776
Research & Development 0.693 1.231 1.038 2.157 1.41
Operating Income -4.321 -5.769 -5.601 -9.697 -8.22
Interest Income (Expense), Net Non-Operating 0.008 0.026 0.027 0.018 -0.01
Other, Net 1.996 -0.324 0.473 5.121 -0.013
Net Income Before Taxes -2.317 -6.067 -5.101 -4.558 -8.243
Net Income After Taxes -2.317 -6.067 -5.101 -4.558 -8.243
Net Income Before Extra. Items -2.317 -6.067 -5.101 -4.558 -8.243
Net Income -2.317 -6.067 -5.101 -4.558 -8.243
Income Available to Common Excl. Extra. Items -2.317 -6.067 -5.101 -4.558 -8.243
Income Available to Common Incl. Extra. Items -2.317 -6.067 -5.101 -4.558 -8.243
Diluted Net Income -2.317 -6.067 -5.101 -4.558 -8.243
Diluted Weighted Average Shares 8.40016 8.31309 8.30382 7.80827 7.48323
Diluted EPS Excluding Extraordinary Items -0.27583 -0.72981 -0.6143 -0.58374 -1.10153
Diluted Normalized EPS -0.27583 -0.72981 -0.60803 -0.58374 -1.10153
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Unusual Expense (Income) 0.052
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 16.309 40.005 18.603 13.41 10.788
Cash and Short Term Investments 13.306 37.18 16.631 11.703 9.36
Cash & Equivalents 13.306 37.18 16.631 11.703 9.36
Total Receivables, Net 1.245 1.027 0.865 0.924 0.786
Accounts Receivable - Trade, Net 1.245 1.027 0.865 0.924 0.786
Total Inventory 0.316 0.174 0.03 0.025 0.092
Prepaid Expenses 1.442 1.624 1.077 0.758 0.55
Total Assets 17.373 41.079 19.605 13.828 11.408
Property/Plant/Equipment, Total - Net 0.65 0.81 0.989 0.353 0.608
Property/Plant/Equipment, Total - Gross 3.461 3.595 3.566 2.734 3.358
Accumulated Depreciation, Total -2.811 -2.785 -2.577 -2.381 -2.75
Other Long Term Assets, Total 0.414 0.264 0.013 0.065 0.012
Total Current Liabilities 5.775 7.84 6 3.978 2.964
Accounts Payable 0.881 1.501 1.103 1.158 0.95
Accrued Expenses 3.727 5.359 3.641 2.588 1.825
Notes Payable/Short Term Debt 0.764 0.779 0.611 0.193 0.189
Other Current Liabilities, Total 0.039 0
Total Liabilities 10.642 10.907 9.886 5.09 4.256
Total Long Term Debt 2.315 2.718 3.477 1.099 1.292
Long Term Debt 2.315 2.718 3.477 1.099 1.292
Capital Lease Obligations 0
Total Equity 6.731 30.172 9.719 8.738 7.152
Common Stock 0.125 0.112 0.105 0.097 0.075
Additional Paid-In Capital 505.504 501.788 449.68 430.802 414.001
Retained Earnings (Accumulated Deficit) -498.898 -471.728 -440.066 -422.161 -406.924
Other Equity, Total
Total Liabilities & Shareholders’ Equity 17.373 41.079 19.605 13.828 11.408
Total Common Shares Outstanding 8.30674 7.47629 6.97501 6.48607 5.03368
Other Liabilities, Total 2.552 0.349 0.409 0.013
Current Port. of LT Debt/Capital Leases 0.403 0.201 0.645
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 7.572 6.862 10.528 16.309 22.976
Cash and Short Term Investments 5.1 4.246 7.535 13.306 20.551
Cash & Equivalents 5.1 4.246 7.535 13.306 20.551
Total Receivables, Net 1.59 1.638 1.554 1.245 1.201
Accounts Receivable - Trade, Net 1.59 1.638 1.554 1.245 1.201
Total Inventory 0.301 0.272 0.302 0.316 0.28
Prepaid Expenses 0.581 0.706 1.137 1.442 0.944
Total Assets 8.662 7.72 11.496 17.373 23.942
Property/Plant/Equipment, Total - Net 0.821 0.603 0.57 0.65 0.716
Other Long Term Assets, Total 0.269 0.255 0.398 0.414 0.25
Total Current Liabilities 5.162 5.374 5.911 5.775 7.297
Accounts Payable 1.382 1.072 0.867 0.881 1.893
Accrued Expenses 3.325 3.737 4.067 3.727 5.061
Notes Payable/Short Term Debt 0.077 0.306 0.535 0.764 0
Current Port. of LT Debt/Capital Leases 0.378 0.259 0.442 0.403 0.343
Total Liabilities 9.321 8.248 10.669 10.642 12.764
Total Long Term Debt 1.217 1.334 2.204 2.315 2.426
Long Term Debt 1.217 1.334 2.204 2.315 2.426
Other Liabilities, Total 2.942 1.54 2.554 2.552 3.041
Total Equity -0.659 -0.528 0.827 6.731 11.178
Common Stock 0.011 0.009 0.008 0.125 0.124
Additional Paid-In Capital 514.544 506.745 505.784 505.504 504.851
Retained Earnings (Accumulated Deficit) -515.214 -507.282 -504.965 -498.898 -493.797
Total Liabilities & Shareholders’ Equity 8.662 7.72 11.496 17.373 23.942
Total Common Shares Outstanding 10.2872 8.47336 8.32954 8.30674 8.29679
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -27.17 -31.662 -17.905 -15.237 -11.371
Cash From Operating Activities -32.185 -27.395 -14.734 -12.966 -9.367
Cash From Operating Activities 0.264 0.302 0.265 0.333 0.675
Non-Cash Items -2.728 2.571 1.577 1.247 1.112
Cash Interest Paid 0.077 0.077 0.037 0.038 0.044
Changes in Working Capital -2.551 1.394 1.329 0.691 0.217
Cash From Investing Activities -0.232 -0.184 -0.49 -0.132 -0.113
Capital Expenditures -0.232 -0.184 -0.49 -0.133 -0.113
Cash From Financing Activities 8.544 48.378 20.152 15.441 13.301
Issuance (Retirement) of Stock, Net 9.013 48.953 6.697 15.63 13.515
Issuance (Retirement) of Debt, Net -0.261 -0.198 2.814 -0.189 -0.214
Net Change in Cash -23.873 20.799 4.928 2.343 3.821
Other Investing Cash Flow Items, Total 0.001
Financing Cash Flow Items -0.208 -0.377 10.641
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -6.067 -27.17 -22.069 -17.511 -9.268
Cash From Operating Activities -5.706 -32.185 -25.109 -16.477 -10.173
Cash From Operating Activities 0.07 0.264 0.195 0.128 0.064
Non-Cash Items 0.159 -2.728 -2.996 1.455 0.842
Cash Interest Paid 0.018 0.077 0.057 0.038 0.02
Changes in Working Capital 0.132 -2.551 -0.239 -0.549 -1.811
Cash From Investing Activities -0.008 -0.232 -0.158 -0.105 -0.082
Capital Expenditures -0.008 -0.232 -0.158 -0.105 -0.082
Cash From Financing Activities -0.055 8.544 8.638 -0.118 -0.07
Financing Cash Flow Items -0.132 -0.208 -0.179 0 0
Issuance (Retirement) of Stock, Net 0.162 9.013 9.013 0.013 0.002
Issuance (Retirement) of Debt, Net -0.085 -0.261 -0.196 -0.131 -0.072
Net Change in Cash -5.769 -23.873 -16.629 -16.7 -10.325
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Schuler (Jack W) Individual Investor 18.4702 1883656 157981 2023-07-24 LOW
Schuler (Henri George) Individual Investor 6.0191 613852 0 2023-03-17
Drysdale (Robert H) Individual Investor 4.6279 471966 44444 2023-03-17 LOW
Sharman (Tanya Schuler) Individual Investor 3.8855 396259 0 2023-03-17
Seamark Capital, LP Hedge Fund 3.7047 377818 7220 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.781 181630 -4 2023-06-30 LOW
B. Riley Wealth Advisors, Inc. Investment Advisor 0.8844 90197 37348 2023-06-30 LOW
Harrington David T Individual Investor 0.67 68333 6333 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.6462 65897 -3 2023-06-30 LOW
Sandford (Nicole) Individual Investor 0.5266 53703 26467 2023-08-29
Townsquare Capital, LLC Investment Advisor 0.4494 45829 29090 2023-03-31 LOW
B. Riley Wealth Management, Inc Research Firm 0.4122 42035 3357 2022-06-30
Jordan (Veronica G H) Individual Investor 0.4082 41626 10814 2023-07-25 LOW
Fraser (John David) Individual Investor 0.4079 41603 6590 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.3907 39846 -5 2023-06-30 LOW
Cavanaugh (Stefanie L CPA) Individual Investor 0.3423 34904 6281 2023-07-24 LOW
Vos (Ellen O'Connor) Individual Investor 0.3224 32878 3769 2023-07-24 LOW
Parnell (Winfred) Individual Investor 0.309 31513 6281 2023-07-24 MED
Quantum Private Wealth, LLC Investment Advisor 0.2781 28362 9529 2023-06-30 LOW
ACT Capital Management, L.L.C. Hedge Fund 0.2727 27808 -15259 2022-09-30 MED

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Aspira Women''s Health Inc.

Aspira Women''s Health Inc., together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women in the United States. It provides OVA1, Overa, and Ova1PLUS to detect the risk of ovarian malignancy. The company also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, it owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. Further, the company is developing diagnostic algorithms; and a high-risk screening algorithm for patients who are genetically predisposed to ovarian cancer. It has entered into a collaborative research agreement with Baylor Genetics to co-develop a novel ovarian cancer early-detection test; and an agreement with Dana Farber Cancer Institute, Brigham and Women''s Hospital, and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies for the development of an early detection test for ovarian cancer. The company has a strategic alliance with Quest Diagnostics, Incorporated. It serves physician office and hospital laboratories, as well as physicians. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women''s Health Inc. in June 2020. Aspira Women''s Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas.
Industry: Bio Diagnostics & Testing

Suite 100
12117 Bee Caves Road Building Three
AUSTIN
TEXAS 78738
US

Income Statement

  • Annual
  • Quarterly

News

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

UK Bank Earnings: What to expect from Lloyds, Barclays and HSBC?

UK banks will be in the spotlight in the week ahead as the European earnings season continues

16:38, 16 February 2024

Is Big Tech behind the apparent bull market rally?

While the Magnificent Seven have dominated market momentum in recent months, it’s not true that they are the sole drivers of the recent rally in equity markets.

16:05, 8 February 2024

US Earnings Week Ahead: Walt Disney, Uber, and Pepsi Co.

The last of the Magnificent Seven have reported, delivering mixed results. Meanwhile, according to FactSet, the S&P 500 is set for negative earnings growth for Q4, with estimates for the next quarter also downgraded.

16:24, 2 February 2024

Bank of England preview: will updated projections show more cuts are expected in 2024?

Markets have no doubt that the BoE will keep its rate unchanged

15:43, 31 January 2024

Meta Platforms Q4 earnings forecast to surge on solid ad revenues

Meta Platforms (META) reports its Q4 results after Wall Street’s closing bell on February 1, 2024. We preview what to expect from the results and analyse the stock’s technicals.

15:33, 31 January 2024

Federal Reserve meeting preview: strong data is making it hard to justify cutting rates

Markets expect the Fed to keep rates unchanged as strong economic data continues

11:30, 30 January 2024

People also watch

Oil - Crude

78.66 Price
+0.870% 1D Chg, %
Long position overnight fee 0.0264%
Short position overnight fee -0.0483%
Overnight fee time 22:00 (UTC)
Spread 0.030

US100

18,091.40 Price
+0.370% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 1.8

XRP/USD

0.60 Price
-0.350% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

Gold

2,043.42 Price
-0.030% 1D Chg, %
Long position overnight fee -0.0195%
Short position overnight fee 0.0112%
Overnight fee time 22:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading